Breaking news on prostate
Men With Reduced Fertility At Reduced Risk For Prostate Cancer published
Fri, 03 Feb 2012 00:00:00 PST
Involuntary childlessness owing to reduced fertility is a concern for many men. However, these men do have one advantage - they run a significantly lower risk of suffering from prostate cancer. Researchers are interested in whether this phenomenon could be used in the fight against cancer. There is a clear link between male subfertility and a lower risk of prostate cancer...
In Patients With Drug-Resistant Prostate Cancer, New Drug Extends Survival published
Thu, 02 Feb 2012 00:00:00 PST
A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression of prostate cancer...
Research Highlights New Treatments, Compares Existing Therapies For Prostate Cancer published
Thu, 02 Feb 2012 00:00:00 PST
Research on promising new therapies and data on the relative benefits of established treatments for prostate cancer have been released, in advance of the fourth annual Genitourinary Cancers Symposium, being held February 2-4, 2012, at the San Francisco Marriott Marquis in San Francisco, Calif...
New Vaccine Approach Discovered For The Treatment Of Cancer published
Mon, 30 Jan 2012 01:00:00 PST
Scientists in Trinity College Dublin, Ireland, have developed a new vaccine to treat cancer at the pre-clinical level. The research team led by Professor Kingston Mills, Professor of Experimental Immunology at Trinity College Dublin discovered a new approach for treating the disease based on manipulating the immune response to malignant tumours...
Shedding Light On Gene Destruction Linked To Aggressive Prostate Cancer published
Sun, 29 Jan 2012 00:00:00 PST
Researchers at Queen's University have identified a possible cause for the loss of a tumour suppressor gene (known as PTEN) that can lead to the development of more aggressive forms of prostate cancer...
Brachytherapy Alone Or In Combination With External Beam Radiation Therapy May Be An Effective Option For High-Risk Prostate Cancers published
Sat, 28 Jan 2012 00:00:00 PST
Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise...
Brachytherapy Lowers Prostate Cancer Mortality published
Fri, 27 Jan 2012 10:00:00 PST
According to a study from radiation oncologists at the Kimmel Cancer Center at Jefferson, high-risk prostate cancer patients who receive brachytherapy, alone or together with external beam radiation therapy (EBRT) had considerably lower mortality rates. The study is published online January 23 in the International Journal of Radiation Oncology*Biology*Physics...
Prostate Cancer - Evidence Not Beliefs Matter Regarding Screening And Treatment published
Thu, 26 Jan 2012 06:00:00 PST
According to Beth Israel Deaconess Medical Center and prostate expert Marc B. Garnick, MD, physicians who advise PSA tests for men being screened for prostate cancer must base their decision more on available evidence when recommending screening, biopsies and treatments, instead of holding on to long held beliefs that PSA-based testing benefits all...
Dutasteride Slows Down Early Stage Prostate Cancer Progression published
Wed, 25 Jan 2012 06:00:00 PST
A study published Online First in The Lancet has found that a common medication (dutasteride) used to treat enlargement of the prostate, may also reduce the need for treatments that pose risks of incontinence and impotence and delay growth of early-stage prostate cancer...
Risk Of Nerve Damage In Prostate Cancer Surgeries May Be Reduced By Preoperative MRI published
Wed, 25 Jan 2012 01:00:00 PST
Preoperative MRI helps surgeons make more informed decisions about nerve-sparing procedures in men with prostate cancer, according to a new study published online in the journal Radiology. Excluding skin cancer, prostate cancer is the most common cancer diagnosed in American men, according to the Centers for Disease Control and Prevention...
Stopping Prostate Cancer Growth - Breakthrough published
Wed, 18 Jan 2012 14:00:00 PST
A study by investigators at the Methodist Research Institute at Indiana University confirms that an all-natural, doctor-designed formula is effective in suppressing prostate cancer tumors. The study conducted on mice, used a human prostate cancer xenograft model. Results from the live animal study were presented by lead researcher, Dr...
Discovery Of First Major Genetic Mutation Associated With Hereditary Prostate Cancer Risk published
Fri, 13 Jan 2012 00:00:00 PST
After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease. A report on the discovery was published in the January 12, 2012 issue of the New England Journal of Medicine...
Nanotechnology Researchers Develop New Strategy To Deliver Chemotherapy To Prostate Cancer Cells published
Wed, 11 Jan 2012 02:00:00 PST
Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge...
How Obesity Affects Cancer Screening published
Wed, 11 Jan 2012 00:00:00 PST
Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women...
Anxiety, Pain During Prostate Biopsies Eased By Headphone Music published
Wed, 11 Jan 2012 00:00:00 PST
Tuning in to tune out may be just what's needed for men undergoing a prostate biopsy, according to researchers at the Duke Cancer Institute. The Duke team found that noise-cancelling headphones playing a classical melody may reduce the pain and anxiety of the often uncomfortable procedure...
PSA Screening Does Not Help Mortality published
Tue, 10 Jan 2012 09:00:00 PST
A study published in the Journal of the National Cancer Institute reveals that there is no difference in mortality rates between men participating in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial, and men who receive usual care after 13 years follow-up. In November 1993, the multi-center, two-arm, PLCO Trial, began enrollment with follow-up, through December 2009...
Indication Of Considerable Added Benefit From Abiraterone In Certain Prostate Cancer Patients published
Tue, 10 Jan 2012 00:00:00 PST
Advantages for men with metastatic hormone-refractory prostate cancer who are no longer eligible for docetaxel therapy Abiraterone (trade name: ZytigaŽ) has been approved since September 2011 for men with metastatic prostate cancer that is no longer responsive to hormone therapy and progresses further during or after therapy with the cytostatic drug docetaxel...
Yearly Prostate Cancer Screening Does Not Lower Total Number Of Deaths published
Mon, 09 Jan 2012 00:00:00 PST
Mass prostate cancer screenings do not lower total number of deaths from prostate cancer, researchers from Washington University School of Medicine at St. Louis reported in the Journal of the National Cancer Institute. They added that mass routine screenings do not even reduce numbers of deaths among males in their fifties and sixties, as well as patients with underlying health conditions...
Proton Therapy Effective Prostate Cancer Treatment published
Sun, 08 Jan 2012 00:00:00 PST
Proton therapy, a type of external beam radiation therapy, is a safe and effective treatment for prostate cancer, according to two new studies published in the January issue of the International Journal of Radiation Oncology.Biology.Physics (Red Journal), the American Society for Radiation Oncology's (ASTRO) official scientific journal...
Angina Medication May Be Effective For Managing Certain Cancers, Study Finds published
Mon, 26 Dec 2011 00:00:00 PST
Researchers at Queen's University have identified a new mechanism that could potentially explain why the body's immune system sometimes fails to eliminate cancer...
Radiotherapy Clinics Of Georgia Present Prostate Cancer Lecture Series published
Sun, 18 Dec 2011 00:00:00 PST
Radiotherapy Clinics of Georgia has announced the details of their Prostate Cancer Lecture Series presented by the physicians of Radiotherapy Clinics of Georgia in January. These courses enable the public to become better educated about prostate cancer and treatment options. All Prostate Cancer Lecture Series seminars are offered free to the public and begin with a light dinner at 5 p.m...
Biopsy Referral After PSA Screening Stays Consistent Over Time published
Thu, 15 Dec 2011 00:00:00 PST
After the US Prostate Cancer Prevention Trial found cancer in many men with low levels of prostate specific antigen (PSA), many debated which PSA level should lead to a biopsy recommendation...
Prostate Cancer - Cardiovascular Risks Linked To Androgen Suppression Therapy Ignored published
Mon, 12 Dec 2011 09:00:00 PST
According to specialists' warnings published in Heart, it has been established that androgen suppression therapy (AST) drugs, that suppress testosterone production for the treatment of prostate cancer, can lead to complications in form of stroke and heart disease, yet standard management of the disease ignores this risk...
PSA Testing, Combined With Other Relevant Patient Data Can Reduce Unnecessary Prostate Biopsies published
Mon, 12 Dec 2011 07:00:00 PST
A study published online by the journal Cancer reveals that up to one-quarter of men could avoid biopsies and their associated risks with prostate cancer screening that combines an adjusted blood test with other factors including, the patient's family history, overall weight as well as the size of the gland. According to the team led by Martin G...
Prostate Cancer - Androgen Deprivation Therapy Does Not Raise Cardiovascular Death Risk published
Thu, 08 Dec 2011 07:00:00 PST
A study published in the December issue of JAMA shows that even though earlier investigations suggested that androgen deprivation therapy designed to inhibit the production of male sex hormones for the treatment of prostate cancer may increase mortality risk from cardiovascular causes, researchers of a meta-analysis of previous randomized trials did not find any links to men wi...
)
|
|
